首页> 美国卫生研究院文献>Annals of Botany >Proposed Criteria for Assessing the Efficacy of Cancer Reduction by Plant Foods Enriched in Carotenoids Glucosinolates Polyphenols and Selenocompounds
【2h】

Proposed Criteria for Assessing the Efficacy of Cancer Reduction by Plant Foods Enriched in Carotenoids Glucosinolates Polyphenols and Selenocompounds

机译:评估通过富含类胡萝卜素芥子油苷多酚和硒化合物的植物性食物减少癌症的功效的拟议标准

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

• Background and Aims The cancer-protective properties of vegetable consumption are most likely mediated through ‘bioactive compounds’ that induce a variety of physiologic functions including acting as direct or indirect antioxidants, regulating enzymes and controlling apoptosis and the cell cycle. The ‘functional food’ industry has produced and marketed foods enriched with bioactive compounds, but there are no universally accepted criteria for judging efficacy of the compounds or enriched foods.• Scope Carotenoids, glucosinolates, polyphenols and selenocompounds are families of bioactive compounds common to vegetables. Although numerous studies have investigated the agricultural and human health implications of enriching foods with one or more of these compounds, inadequate chemical identification of compounds, lack of relevant endpoints and inconsistencies in mechanistic hypotheses and experimental methodologies leave many critical gaps in our understanding of the benefits of such compounds. This review proposes a decision-making process for determining whether there is reasonable evidence of efficacy for the both the compound and the enriched food. These criteria have been used to judge the evidence of efficacy for cancer prevention by carotenoids, polyphenols, glucosinolates and selenocompounds.• Conclusions The evidence of efficacy is weak for carotenoids and polyphenols; the evidence is stronger for glucosinolates and lycopene, but production of enriched foods still is premature. Additionally there is unacceptable variability in the amount and chemical form of these compounds in plants. The evidence of efficacy for selenocompounds is strong, but the clinical study that is potentially the most convincing is still in progress; also the variability in amount and chemical form of Se in plants is a problem. These gaps in understanding bioactive compounds and their health benefits should not serve to reduce research interest but should, instead, encourage plant and nutritional scientists to work together to develop strategies for improvement of health through food.
机译:•背景和目的蔬菜食用的抗癌特性很可能是通过“生物活性化合物”介导的,这些化合物可诱导多种生理功能,包括充当直接或间接的抗氧化剂,调节酶并控制细胞凋亡和细胞周期。 “功能食品”行业已经生产并销售了富含生物活性化合物的食品,但尚无公认的判断该化合物或富含食品的功效的标准。•范围类胡萝卜素,芥子油苷,多酚和硒化合物是蔬菜中常见的生物活性化合物家族。尽管许多研究已经调查了用一种或多种这些化合物富集食物对农业和人类健康的影响,但化合物的化学鉴定不足,缺乏相关的终点以及机械学说和实验方法的不一致,在我们对收益的理解上仍存在许多重大差距这类化合物。这篇综述提出了一种决策过程,用于确定该化合物和浓缩食品是否都具有合理的功效证据。这些标准已被用来判断类胡萝卜素,多酚,芥子油苷和硒化合物对预防癌症的功效。结论结论对类胡萝卜素和多酚的功效证据不充分。关于芥子油苷和番茄红素的证据更充分,但生产富含食品的食物仍为时过早。另外,植物中这些化合物的数量和化学形式的变化是不可接受的。硒代化合物的功效的证据很充分,但可能仍最具说服力的临床研究仍在进行中。植物中硒的含量和化学形式的变化也是一个问题。在理解生物活性化合物及其健康益处方面的这些差距不应有助于减少研究兴趣,而应鼓励植物和营养科学家共同制定通过食物改善健康的策略。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号